From COVID-19 to polio to monkeypox, infectious disease threats have dominated the headlines and public discourse in recent weeks.
Public Health
People exposed to someone infected with the coronavirus, vaccinated or not, no longer need to quarantine, according to updated CDC guidance released Aug. 11. The new COVID-19 recommendations focus on mitigating the risk of severe disease, rather than infection itself.
Johns Hopkins Bloomberg School of Public Health has launched a free virtual course on infectious disease transmission models for public health officials and practitioners who make policy decisions.
Here are 10 COVID-19-related studies Becker's has covered since July 18:
Countries in the middle or just past the peak of a surge driven by the BA.5 omicron subvariant, such as the U.S., likely won't experience a subsequent wave from BA.2.75, another omicron relative, some experts predict.
Advertisement
The manufacturer of the Jynneos monkeypox vaccine, Bavarian Nordic, voiced concerns to federal health officials about efforts to expand vaccine supplies by allowing the administration of fractional doses, The Washington Post reported Aug. 10.
The CDC may offer some New Yorkers an extra dose of the polio vaccine amid concerns that the virus is silently spreading through a community where the nation's first polio case in nearly a decade was detected July 21, CNN…
A new virus has appeared to jump from animals to humans for the first time, infecting 35 people in China, according to a research letter published Aug. 4 in The New England Journal of Medicine.
The BA.5 omicron subvariant has maintained its dominance since early July, accounting for 87 percent of U.S. COVID-19 cases for the week ending Aug. 6, according to the CDC's latest variant proportions update.
The FDA on Aug. 9 issued an emergency use authorization for a strategy that will expand the nation's supply of the Jynneos monkeypox vaccine and allow high-risk children under the age of 18 to receive it. The move comes as…